NIH

Dear Research Advocate: We celebrated steadfast advocates for research to improve health at last week’s Advocacy Awards Dinner; pictures are now available. Champions like Whitehead awardees Chairmen Blunt and Cole keep us energized in the fight for medical research, even in the face of its virtual absence on the presidential campaign trail. Indeed, Research!America Chairman, Hon. John Porter, urged everyone present to take it upon themselves, as advocates, to make it clear how vital this election is to the future of science, research, and health. Since this is the mission of Campaign for Cures and related Research!America election-year activities, we can help you in your advocacy! Our...
Dear Research Advocate: Three outstanding speakers addressed Research!America’s annual meeting of members yesterday. Newly confirmed FDA Commissioner Dr. Robert Califf kicked off the meeting, outlining his priorities for the agency. Having known Dr. Califf for some time, I wasn’t at all surprised to hear how determined he is to ensuring FDA engages the patient perspective as it works to improve policies and processes. For example, he underscored how important it is to calibrate risk/benefit calculations to take into account the seriousness of an illness and the availability of treatment options...in other words, how important it is to think like a patient, not for a patient. Bravo! Senator...
In this new series of videos , we illustrate the urgent need for exploring opportunities to increase scientific understanding of lupus using recommendations from the recently released Action Plan for Lupus Research . The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), released the action plan to identify and examine opportunities to increase scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, cures. Lupus is an unpredictable and misunderstood autoimmune disease that ravages different parts of the body. It is difficult to diagnose, hard to live...
Dear Research Advocate: Our Annual Members Meeting and Advocacy Awards Dinner are coming up on March 16. There is still time to register for both the meeting , where we will hear remarks from Senator Amy Klobuchar (D-MN), FDA Commissioner Robert Califf, M.D., and ALS patient-advocate Lorri Carey, and the dinner , where we will be presenting awards to a distinguished group of research and innovation champions and world class advocates. Join us for an inspiring day! Yesterday, the Senate HELP committee passed a second set of seven bipartisan “Innovations” bills, which focus on a range of topics including combination products, patient input on all aspects of clinical trials and health IT. See...
Dear Research Advocate: I’m pleased to announce that Senator Amy Klobuchar (D-MN) will be giving remarks at our Annual Meeting on March 16 at noon at the Willard Intercontinental Hotel. We will also be hearing from newly confirmed FDA commissioner Dr. Robert Califf and ALS patient advocate Lorri Carey. I hope you’ll join us at the annual meeting as well as at the Annual Advocacy Awards Dinner that evening. See our ad in Roll Call . Senators Patty Murray (D-WA) and Elizabeth Warren (D-MA) were joined by the eight other democratic members of the Senate HELP Committee today as they introduced the National Biomedical Research Act . This bill would provide a new mandatory funding stream for NIH...
Research conducted at Louisiana institutions benefits not only those in the state but also people across the country, said Senator Bill Cassidy (R-LA) during his opening remarks at the Louisiana Research Summit held on February 16 at the University Medical Center in New Orleans. The summit, co-hosted by Research!America, assembled federal, state, university, and business leaders to discuss current challenges and opportunities for advancing research in Louisiana. At several junctures during the summit, Senator Cassidy stressed the importance of making Louisiana "easy to work with" by lowering administrative barriers and building on success to date. He also emphasized that the summit was not...
Dear Research Advocate: This week I had the pleasure of participating in a research “summit” hosted by Louisiana State University (LSU), Research!America, and our honorary host, Senator Bill Cassidy (R-LA). I moderated a powerhouse panel featuring NIH Director Francis Collins, M.D., NSF Director France Cordova, Ph.D., and FDA’s Center for Drug Evaluation and Research (CDER) Director Janet Woodcock, M.D., each of whom offered state-specific illustrations of the impact federally-funded Louisiana research has had to date, and signalled the many opportunities Louisiana has to do more. This standing-room-only, high-content gathering drew research, academic, business and philanthropic leaders...
Dear Research Advocate: As task force meetings for Vice President Biden’s “moonshot” initiative began this week, a new public opinion survey commissioned by Research!America showed that 50% of Americans favor a tax increase to fund cancer research. While this manner of funding the moonshot is not currently on the table, the survey finding underscores the high priority Americans place on curing cancer. The President told Majority Leader McConnell and Speaker Ryan that assuring resources for research, cancer in particular, is one of his five priorities for working across the aisle this year. His FY17 budget proposal -- scheduled for release next Tuesday -- will reportedly request additional...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), recently released a new report, the Action Plan for Lupus Research to assess opportunities for increasing scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, curative strategies. The report reflects the current need and gap in lupus research for helping to improve upon a basic understanding of the disease and to identify targets for advancing lupus drug development. Lupus is an unpredictable and misunderstood autoimmune disease that ravages different parts of the body. It is difficult to diagnose...
This was an exceptional year for publicly-funded research projects. Investments in science led to a greater understanding of preventing and treating disease such as using genetic variants to identify people at risk for coronary heart disease and tailoring breast cancer treatments to avoid the need for chemotherapy. The National Institutes of Health (NIH) also supported the work of three Nobel Prize winners and clinical advances in cancer, heart disease, MS and many other conditions. The National Science Foundation (NSF) funded interdisciplinary projects including one that led to a holistic approach to strengthening the security and effectiveness of mobile medical applications . Evidence-...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor